Alkermes
ALKS
#2770
Rank
$5.89 B
Marketcap
$35.36
Share price
17.28%
Change (1 day)
7.09%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): $0.30 Billion USD

According to Alkermes's latest financial reports the company's current earnings are $1.47 Billion USD. a decrease over its 2024 earnings that were of $0.46 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1996 to 2025

Annual earnings

Year Earnings Change
2025 $0.30 B-34.87%
2024 $0.46 B-17.97%
2023 $0.56 B-468.52%
2022 -$0.16 Billion449.24%
2021 -$28.09 Million-68.04%
2020 -$87.88 Million-52.1%
2019 -$0.19 Billion64.49%
2018 -$0.12 Billion-15.04%
2017 -$0.14 Billion-34.2%
2016 -$0.2 Billion-5.34%
2015 -$0.22 Billion35084.97%
2014 -$0.6 Million
2012 $7.42 M-117.81%
2011 -$41.69 Million-12.69%
2010 -$47.74 Million94.3%
2009 -$24.57 Million-117.7%
2008 $0.13 B622.63%
2007 $19.21 M
2004 -$75.98 Million-14.48%
2003 -$88.84 Million11.88%
2002 -$79.41 Million39.65%
2001 -$56.86 Million5.73%
2000 -$53.78 Million-28.91%
1999 -$75.65 Million237.28%
1998 -$22.43 Million100.05%
1997 -$11.22 Million-37.93%
1996 -$18.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$33.55 B 10,946.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.35 B 5,283.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$10.19 B 3,255.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$7.69 B 2,434.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
$9.32 B 2,971.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$14.10 B 4,544.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-$0.22 Billion-169.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-$0.28 Billion-189.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$2.15 B 608.53%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel